Princeton Junction, NJ, United States of America

Jeffrey Lockman

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Jeffrey Lockman

Introduction

Jeffrey Lockman, an accomplished inventor based in Princeton Junction, NJ, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio comprising ten patents, Lockman's work primarily focuses on innovative compounds that hold promise for treating various disorders, especially those related to pain management.

Latest Patents

Lockman's recent patents showcase his expertise and creativity in developing novel pharmaceutical compounds. One of his notable inventions includes 6-substituted and 7-substituted morphinan analogs, which are aimed at treating disorders responsive to the modulation of opioid receptors. The application underlines the importance of compounds defined as Formula I or II and their pharmaceutically acceptable salts and solvates, emphasizing their potential effectiveness in pain treatment.

Another significant patent relates to substituted pyrimidine carboxamides as sodium channel blockers. This innovation offers compounds of Formula (I) that can potentially address disorders that respond to sodium channel blockade, reinforcing his commitment to advancing pain treatment solutions.

Career Highlights

Throughout his career, Jeffrey Lockman has established himself as a prominent figure in pharmaceutical innovation. He has collaborated with renowned companies, including Purdue Pharma L.P., where he applied his inventive skills to develop cutting-edge therapeutics. His extensive experience and contributions have positioned him as a leader in his field.

Collaborations

Lockman’s journey has been enriched through collaborations with talented individuals such as Laykea Tafesse and Jae Hyun Park. Working together, they have explored new frontiers in drug development, often focusing on improving patient outcomes through innovative pharmaceutical strategies.

Conclusion

In conclusion, Jeffrey Lockman stands out as an influential inventor in the pharmaceutical sector, with a track record of patents that highlight his dedication to addressing pain management through innovative compounds. His work continues to pave the way for future advancements in medical therapies, ensuring that patients can benefit from novel treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…